You have 9 free searches left this month | for more free features.

Alum

Showing 26 - 50 of 199

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HIV Trial in United States (MN rgp120/HIV-1 and A244 rgp120/HIV-1, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • MN rgp120/HIV-1 and A244 rgp120/HIV-1
  • +2 more
  • Baltimore, Maryland
  • +3 more
Oct 28, 2021

COVID-19 Trial in Taiyuan, Chengdu (Candidate Vaccine, SCB-2019, Placebo)

Active, not recruiting
  • COVID-19
  • Candidate Vaccine, SCB-2019
  • Placebo
  • Taiyuan, Shanxi, China
  • +1 more
Feb 22, 2022

COVID-19 Trial in Semarang, Makassar, Padang (SARS-CoV-2 protein subunit recombinant vaccine, )

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 protein subunit recombinant vaccine
  • placebo
  • Semarang, Central Java, Indonesia
  • +2 more
Aug 8, 2022

Diabetes, Type 1, Prediabetic State Trial in Malmö (Alum-GAD, Vitamin D3)

Terminated
  • Diabetes Mellitus, Type 1
  • Prediabetic State
  • Malmö, Sweden
    Clinical Research Center, Pediatric Endocrinology, Jan Waldenstr
Oct 27, 2020

COVID-19 Trial in Indonesia (COVID-19 Protein Subunit Recombinant Vaccine, Active Comparator)

Recruiting
  • COVID-19
  • COVID-19 Protein Subunit Recombinant Vaccine
  • Active Comparator
  • Semarang, Central Java, Indonesia
  • +3 more
Jun 26, 2022

Hiv Trial in United States (V3G CH848 Pr-NP1 60mcg, 3M-052-AF 5mcg, Alum 500 mcg)

Not yet recruiting
  • Hiv
  • V3G CH848 Pr-NP1 60mcg
  • +5 more
  • Birmingham, Alabama
  • +5 more
Jun 5, 2023

Pertussis, Vaccine-Preventable Diseases Trial in Geneva (Pertagen®, Revaxis®)

Recruiting
  • Pertussis
  • Vaccine-Preventable Diseases
  • Geneva, Switzerland
    University of Geneva
Jan 11, 2022

HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)

Not yet recruiting
  • HIV Infections
  • sD-NP-GT8 DNA
  • +4 more
  • Birmingham, Alabama
  • +5 more
Mar 10, 2023

Chikungunya Virus Infection Trial in Lenexa, Kansas City, West Jordan (CHIKV VLP/unadjuvanted, CHIKV VLP/adjuvanted, Placebo)

Completed
  • Chikungunya Virus Infection
  • CHIKV VLP/unadjuvanted
  • +2 more
  • Lenexa, Kansas
  • +2 more
Oct 12, 2021

HIV Trial in Mozambique, South Africa, Zimbabwe (ALVAC-HIV (vCP2438), Bivalent Subtype C gp120/MF59, Bivalent Subtype C gp120

Completed
  • HIV Infections
  • ALVAC-HIV (vCP2438)
  • +3 more
  • Maputo, Mozambique
  • +5 more
Nov 18, 2021

Diabetes, Type 1 Trial in Sweden (GAD-Alum, Vitamin D, Etanercept)

Completed
  • Diabetes Mellitus, Type 1
  • Helsingborg, Sweden
  • +7 more
Mar 26, 2021

Respiratory Syncytial Virus Trial run by the NIAID (VRC-RSVRGP084-00-VP, Aluminum Hydroxide Suspension)

Completed
  • Respiratory Syncytial Virus
  • VRC-RSVRGP084-00-VP
  • Aluminum Hydroxide Suspension
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 21, 2020

HIV, HIV Seronegativity Trial in Baltimore (Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203), Aluminum hydroxide, MF59)

Completed
  • HIV Infections
  • HIV Seronegativity
  • Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)
  • +3 more
  • Baltimore, Maryland
    JHU AVEG
Oct 27, 2021

Staphylococcal Infections, Yeast Infections, Candidiasis Trial in Fargo (NDV-3 vaccine with alum IM, NDV-3 vaccine without alum

Completed
  • Staphylococcal Infections
  • +2 more
  • NDV-3 vaccine with alum IM
  • +3 more
  • Fargo, North Dakota
    Cetero Research Clinical Site
Feb 20, 2020

Zika Virus Infection Trial in Silver Spring (IXIARO, Placebo, YF Vax 17D Strain)

Completed
  • Zika Virus Infection
  • IXIARO
  • +3 more
  • Silver Spring, Maryland
    Walter Reed Army Institute of Research - Clinical Trials Center
Sep 3, 2020

COVID-19 Trial in Worldwide (CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Placebo; 0.9% saline, SCB-2019 vaccine)

Recruiting
  • COVID-19
  • CpG 1018/Alum-adjuvanted SCB-2019 vaccine
  • +3 more
  • Alken, Belgium
  • +30 more
Feb 7, 2022

Venezuelan Equine Encephalitis, Western Equine Encephalitis, Eastern Equine Encephalitis Trial in Decatur (VRC-WEVVLP073-00-VP,

Completed
  • Venezuelan Equine Encephalitis
  • +3 more
  • VRC-WEVVLP073-00-VP
  • VRC-GENMIX083-AL-VP
  • Decatur, Georgia
    The Hope Clinic of the Emory Vaccine Center
Mar 23, 2021

Diabetes, Type 1 Trial in Linköping (GAD-Alum, Vitamin D)

Completed
  • Diabetes Mellitus, Type 1
  • Linköping, Sweden
    Linköping University
Apr 15, 2020

Type 1 Diabetes Trial in Canada, United States (GAD-Alum, GAD-Alum and Aluminum hydroxide, Aluminum hydroxide)

Completed
  • Type 1 Diabetes Mellitus
  • Los Angeles, California
  • +14 more
Apr 27, 2020

Taste-aware Intelligent Analysis of Oral Nutritional Supplements

Not yet recruiting
  • Cancer- and Cancer Treatment-Related Conditions
  • Stroke
  • Samples materials of basic taste stimuli and enteral nutrition preparations
  • Beijing, Beijing, China
    Dongcheng district,Peking union medical college hospital
Dec 5, 2022

Induced by Allergy Immunotherapy (AIT) With Different Adjuvants

Completed
  • Allergic Rhinitis
  • Allergovit
  • +2 more
  • Zurich, Switzerland
    Univeristy Hospital Zurich
Mar 22, 2022

Shingles, Herpes Zoster, Vaccine-Preventable Diseases Trial in Australia (Z-1018, Shingrix)

Recruiting
  • Shingles
  • +2 more
  • Z-1018
  • Shingrix
  • Blacktown, New South Wales, Australia
  • +3 more
Feb 8, 2022

HIV Trial in Boston (CH505 TF chTrimer, 3M-05-AF, Aluminum hydroxide suspension)

Active, not recruiting
  • HIV Infections
  • CH505 TF chTrimer
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's CRS
Jan 31, 2022

Pneumonia, Pneumococcal Trial in Kisumu (PATH-wSP, Synflorix, Pentavac)

Completed
  • Pneumonia, Pneumococcal
  • PATH-wSP
  • +3 more
  • Kisumu, Nyanza, Kenya
    Kenya Medical Research Institute/Walter Reed Project
Oct 1, 2019

COVID-19 Vaccine Trial in Argentina (Gamma Variant RBD-based ARVAC-CG vaccine, Omicron Variant RBD-based ARVAC-CG vaccine,

Recruiting
  • COVID-19 Vaccine
  • Gamma Variant RBD-based ARVAC-CG vaccine
  • +3 more
  • Argentina, C.a.b.a., Argentina
    Centro de Educación Médica e Investigaciones Clínicas "Norberto
Feb 28, 2023